retatrutide resting heart rate Low dose reta update Retatrutide and Heart Issues: Cardiovascular

Measurable weight loss is typically visible by weeks 4-8

In clinical trials, retatrutide has been administered as a subcutaneous injection meaning it is injected into the fatty tissue just beneath the skin once weekly

Sustainable fat loss requires a system that: Works with your metabolism Preserves muscle and strength Supports insulin signaling Maintains long-term energy Weight loss should improve how you feel not slowly dismantle your physiology

Mechanism of Action: The Triple Agonist Synergy The therapeutic efficacy of retatrutide is derived from its ability to engage three primary metabolic pathways simultaneously, creating a multi-systemic response that targets the root causes of obesity and metabolic dysfunction